Excerpt from Reuters quoting DataTrek’s Jessica Rabe:
…. “Gaining exposure to the U.S. market would be a plus for Canopy, but since public marijuana companies’ stocks are low-priced, “any move is amplified because markets expect little from these names,” Jessica Rabe, co-founder of DataTrek Research, said in an e-mail…
…Federal legalization of marijuana in the United States could still be “a long way off, especially if Republicans take back Congress in the upcoming mid-term elections,” she said, and cannabis companies need to navigate many U.S. state laws and regulations”….
Full article here on Reuters!